Gastroenterology & Hepatology Advanced Practice Providers (GHAPP)

GHAPPcast

Health EN ↓ Epizody: 157

This is the official podcast of The Gastroenterology & Hepatology Advanced Practice Providers (GHAPP), an association is dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs). Through our peer-to-peer network, we seek to support their integral role in the specialty healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with gastrointestinal (GI) disorders and chronic liver disease (CLD).

Autor

Gastroenterology & Hepatology Advanced Practice Providers (GHAPP)

Kategorie

Health

Web podcastu

ghappcast.captivate.fm

Nejnovější epizoda

30. čvn 2026

Kde poslouchat?

Podcasty v aplikaci Replaio Radio Už brzy

Podcasty míří do aplikace už brzy. Nainstaluj si ji teď a jako první uvidíš úplně nový pohled na podcasty

Nainstaluj zdarma Android téměř 10 mil. stažení · hodnocení 4,8 iOS už brzy

Epizody

Managed Care and Biosimilars 03.10.2023 24:23

In the seventh episode of the GHAPP & RhAPP biosimilar podcast series host Amanda Mixon, PA-C, and guest Audrey Gibson, PA-C discuss the interplay between managed care and biosimilars. The learning objectives for this episode are to: Discuss managed care implications for biosimilars reaching the market Identify the benefits of biosimilars in managed care Formulate strategies managed care profe...

Interchangeability & Switching of Biosimilars 15.09.2023 31:04

For our sixth episode of the GHAPP & RhAPP biosimilar podcast series host Gabriella McCarty, NP-C, and guest Janette Villalon, NP discuss interchangeability & switching of biosimilars. The learning objectives and goals for this episode are to: -Define interchangeability -Illustrate the required info for a biosimilar to be deemed interchangeable by the FDA -Recognize how interchangeability...

Biosimilar Extrapolation 23.08.2023 33:49

In the fifth episode of the GHAPP & RhAPP biosimilar podcast series host Amanda Mixon, PA-C, and guest Betsy Kirchner, DNP review the important concept of biosimilar extrapolation. The learning objectives for this episode are to: Define extrapolation Understand why extrapolation is important. Understand the key aspects that may be considered for scientific justification of extrapolation includ...

The Difference Between Biosimilars & Generic Drugs 08.08.2023 20:18

In the fourth episode of the GHAPP & RhAPP biosimilar podcast series host Gabriella McCarty, NP and guest Tedra Gray, NP discuss the differences between biosimilars and generic drugs. The learning objectives and goals for this episode are to: -Compare and contrast biosimilars and generics regarding: -Molecular size and structure -Complexity of development -Cost of d...

The Regulatory Pathway to Biosimilar Approval 25.07.2023 22:06

Welcome to our third episode of the GHAPP & RhAPP biosimilar podcast series! In this episode host Amanda Mixon, PA-C has an in-depth conversation with the incredible Danielle Gatti-Palumbo, PharmD, BCACP, AAHIVP, about The Regulatory Pathway to Biosimilar Approval. The learning objectives and goals for this episode are to: -Summarize the totality of evidence approach to determining biosimilar...

Development of Biosimilars 13.07.2023 27:19

Join us for our second episode of the GHAPP & RhAPP biosimilar podcast series! In this episode host Amanda Mixon, PA-C discusses the Development of Biosimilars with our esteemed guest Tanya Golovanoff, PharmD. The learning objectives and goals for this episode are to: -Distill the immense amount of research and development that occurs to develop biosimilars -Articulate the biosimilar manufactu...

Biosimilars Series: What Are Biosimilars? 14.06.2023 33:01

Join us for the first episode of the GHAPP & RhAPP biosimilar podcast series! In this episode Gabriella McCarty, NP-C and Jennifer Geremia, PA-C discuss What Are Biosimilars? The learning objectives and goals for this episode are to: -Define biologic therapy -Define biosimilars -Define reference product -Summarize the impact of The Biologics Price Competition and Innovation Act Please take our...